Most people spend hours researching which peptide to run.
Almost nobody spends five minutes understanding how long that peptide actually stays active in the body.
That’s a problem.
Here’s the concept: every peptide has a half-life — the time it takes for the concentration in your system to drop by 50%. This isn’t a minor detail. It’s the single biggest factor that determines whether your dosing schedule makes sense or whether you’re working against your own biology.
A quick example to make this concrete:
CJC-1295 (with DAC) has an estimated half-life of around 6–8 days in research models. That means it lingers in the system. Stacking frequent doses doesn’t just waste supply — it can push circulating levels beyond what the receptor pathway was designed to handle, which can desensitize the very receptors you’re trying to activate.
Compare that with Modified GRF (1-29), which has a much shorter half-life — roughly 30 minutes. If you dose it once per day and expect sustained GH signaling, you’re missing the window entirely. The compound is largely inactive by the time your next meal or sleep cycle rolls around.
The mechanism matters here:
Short half-life compounds require more precise timing — often paired around sleep or fasting windows to align with natural GH pulses.
Long half-life compounds require less frequent dosing but demand more awareness of cumulative receptor saturation over time.
This is why copying someone else’s protocol rarely works. Two people can run the exact same compound at the exact same dose — but if their timing doesn’t match the pharmacokinetics, they’ll get completely different outcomes.
The takeaway: before you think about dose, think about duration. Understanding half-life is the difference between a protocol that works with your biology and one that fights against it.
We’re breaking down specific half-life profiles for GH secretagogues, metabolic peptides, and repair compounds inside the Discord this week. If you want to go deeper, that’s where the conversation is happening.
Stay curious,
The Biohacker Network